March 30, 2020

Terren Peizer
Chairman and Chief Executive Officer
BioVie Inc.
2120 Colorado Avenue #230
Santa Monica, CA 90404

       Re: BioVie Inc.
           Amendment No. 9 to Registration Statement on Form S-1
           Filed March 11, 2020
           File No. 333-231136

Dear Mr. Peizer:

       We have limited our review of your registration statement to those
issues we have
addressed in our comment. In our comment, we may ask you to provide us with
information so
we may better understand your disclosure.

       Please respond to this letter by amending your registration statement
and providing the
requested information. If you do not believe our comment applies to your facts
and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information you
provide in response to the comment, we may have additional comments.

Amendment No. 9 to Registration Statement on Form S-1 filed March 11, 2020

Cover page

1.     Please expand your disclosure to state the date the offering will end.
Additionally, state
       whether the Company has made arrangements for funds to be placed in
escrow and if not,
       state this fact and describe the effect on investors. Refer to Item
501(b)(8)(iii) of
       Regulation S-K.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.
 Terren Peizer
BioVie Inc.
March 30, 2020
Page 2

        Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

      Please contact Christine Westbrook at 202-551-5019 or Mary Beth Breslin
at 202-551-
3625 with any questions.



                                                           Sincerely,
FirstName LastNameTerren Peizer
                                                           Division of
Corporation Finance
Comapany NameBioVie Inc.
                                                           Office of Life
Sciences
March 30, 2020 Page 2
cc:       Mitchell S. Nussbaum, Esq.
FirstName LastName